Hoefflin, R.; Lazarou, A.; Hess, M.E.; Reiser, M.; Wehrle, J.; Metzger, P.; Frey, A.V.; Becker, H.; Aumann, K.; Berner, K.;
et al. Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. Cancers 2021, 13, 1151.
https://doi.org/10.3390/cancers13051151
AMA Style
Hoefflin R, Lazarou A, Hess ME, Reiser M, Wehrle J, Metzger P, Frey AV, Becker H, Aumann K, Berner K,
et al. Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. Cancers. 2021; 13(5):1151.
https://doi.org/10.3390/cancers13051151
Chicago/Turabian Style
Hoefflin, Rouven, Adriana Lazarou, Maria Elena Hess, Meike Reiser, Julius Wehrle, Patrick Metzger, Anna Verena Frey, Heiko Becker, Konrad Aumann, Kai Berner,
and et al. 2021. "Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis" Cancers 13, no. 5: 1151.
https://doi.org/10.3390/cancers13051151
APA Style
Hoefflin, R., Lazarou, A., Hess, M. E., Reiser, M., Wehrle, J., Metzger, P., Frey, A. V., Becker, H., Aumann, K., Berner, K., Boeker, M., Buettner, N., Dierks, C., Duque-Afonso, J., Eisenblaetter, M., Erbes, T., Fritsch, R., Ge, I. X., Geißler, A.-L.,
... von Bubnoff, N.
(2021). Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. Cancers, 13(5), 1151.
https://doi.org/10.3390/cancers13051151